The Use of Low Molecular Weight Heparin in Traumatic Brain Injury

Status Completed

Clinical Trial Summary

To study the safety and efficacy of early administration of Low Molecular Weight Heparin to patients with traumatic brain injury.

Clinical Trial Description

Venous thromboembolic (VTE) prophylaxis in trauma patients is a critical clinical problem. Patients with traumatic brain injury usually have effective VTE prophylaxis withheld secondary to concerns of exacerbating intracranial hemorrhage. This study examines the safety and efficacy of early administration (within 24 hrs of admission) of low molecular weight heparin to this patient population with very high VTE risk. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00170378
Study type	Interventional
Source	Minneapolis Medical Research Foundation
Contact
Status	Completed
Phase	Phase 4
Start date	December 2002
Completion date	August 2005

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02567903` - Tourniquet Study: A Clinical Trial Into the Effect of Tourniquet Use on the Coagulation System	N/A
Completed	`NCT02247414` - Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection	Phase 4
Recruiting	`NCT02650453` - Ongoing Registry of Deep Venous Reconstructions	N/A
Completed	`NCT00839657` - Clarification of Optimal Anticoagulation Through Genetics	Phase 3
Completed	`NCT02065388` - Pharmacogenetic Dosing of Warfarin	Phase 3
Terminated	`NCT00872079` - Personalized Warfarin Dosing by Genomics and Computational Intelligence	N/A
Terminated	`NCT00521885` - Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients	N/A
Completed	`NCT00346424` - Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters	Phase 3
Completed	`NCT02892565` - Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System)	N/A
Active, not recruiting	`NCT04349189` - Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait
Recruiting	`NCT02238444` - Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy	Phase 4
Recruiting	`NCT02597218` - Incidence of Venous Thromboembolic Disease and Portal Vein Thrombosis After Hepatectomy. A Cohort Study.
Completed	`NCT00986154` - Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).	Phase 3
Completed	`NCT00246025` - A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery.	Phase 2
Completed	`NCT00097357` - BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery	Phase 2/Phase 3
Completed	`NCT04645550` - Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）	Phase 4
Recruiting	`NCT02264743` - Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy	Phase 4
Completed	`NCT01482273` - Ultrasound-enhanced Thrombolysis Versus Standard Catheter Directed Thrombolysis for Ilio-femoral Deep Vein Thrombosis	N/A
Recruiting	`NCT01252420` - Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis	Phase 4
Completed	`NCT01145859` - Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects	Phase 1